| AC | alcoholic cirrhosis |
| ACLF | acute-on-chronic liver failure |
| AH | alcohol-associated hepatitis |
| ALD | alcohol-related liver disease |
| AUC | area under the ROC curve |
| cACLD | compensated advanced chronic liver disease |
| CSPH | clinically significant portal hypertension |
| ELF | Enhanced Liver Fibrosis test |
| eNAMPT | extracellular nicotinamide phosphoribosyltransferase |
| FIB-4 | Fibrosis-4 index |
| HOMA-IR | homeostasis model assessment of insulin resistance |
| HVPG | hepatic venous pressure gradient |
| iNAMPT | intracellular nicotinamide phosphoribosyltransferase |
| MASLD | metabolic dysfunction-associated steatotic liver disease |
| MetALD | metabolic dysfunction and alcohol-related liver disease |
| NAFLD | non-alcoholic fatty liver disease |
| NAMPT | nicotinamide phosphoribosyltransferase |
| NOS | Newcastle-Ottawa Scale |
| PBC | primary biliary cholangitis |
| PEth | phosphatidylethanol |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RBP-4 | retinol-binding protein 4 |
| SLD | steatotic liver disease |
| SWiM | Synthesis Without Meta-Analysis |
| TLR4 | Toll-like receptor 4 |